BMW's Margin Pledge Becomes the Real Test as Price Targets Come Down

Two brokerage notes landed on BMW on the same day, and neither carried a downgrade. ODDO BHF cut its price target to EUR 52 from EUR 55 while keeping a "Neutral" rating, and Deutsche Bank Research trimmed its own target to EUR 66 from EUR 71 without touching its Buy recommendation. The message is not that the Munich carmaker has lost its appeal — it is that the numbers behind the story have become harder to pin down.

Both moves followed BMW's quarterly release and a lowered margin outlook, and both point to the same fault line: how much of the current weakness is restructuring, and how much is the business itself.

What the quarter actually showed

BMW reported third-quarter 2026 group revenue of EUR 30,452 million. Pre-tax profit came in at EUR 2,083 million, down 10.6% year on year. The automotive segment's EBIT margin for the quarter was 3.4%, and for the first nine months of 2026 the group posted pre-tax earnings of EUR 6,128 million.

Those figures sit alongside a full-year guidance cut. BMW now expects an automotive EBIT margin of between ?0.5% and +0.5%, citing expanded and accelerated portfolio and structural measures whose non-operating costs will weigh on the fourth quarter. The company also flagged a moderate decline in deliveries, having previously guided for a slight one. Free cash flow in the automotive segment is still expected to exceed EUR 2.5 billion, and return on capital employed is projected at between ?1% and +1%.

The number that matters most

Buried in that guidance is the figure that now carries the most analytical weight: before these measures, BMW still expects an automotive margin above 2.0%. That distinction is the crux of the debate. Reported profitability absorbs the overhaul costs; the pre-measures expectation offers a separate read on underlying earning power.

Neither figure should be used to cancel out the other. The charges are real, and they do hit earnings. But it would be equally short-sighted to read the reported margin as a direct proxy for profitability before the interventions. The test for investors is whether BMW can hold the pre-measures expectation — a further softening there would make the restructuring explanation far less convincing.

Deutsche Bank's Tim Rokossa framed his note around exactly this uncertainty, highlighting the restructuring and the limited visibility into 2027. JPMorgan's Jose M. Asumendi, who cut his target to EUR 68 from EUR 82 a day earlier while keeping a positive rating, factored in the announced one-off overhaul costs and sharply reduced his adjusted EBIT forecasts for both 2026 and 2027. That revision matters: it limits how much reassurance can be drawn from a view focused solely on the fourth quarter.

A split picture on volumes

The bear case is straightforward. Cheaper restructuring would help little if the underlying business keeps sliding. Reuters reported a marked sales decline in China during the summer quarter, only partly offset by growth in Europe and the US — regional divergence, not evidence of stable overall demand. Should weaker deliveries compound the pressure on earning power, the expected relief from the overhaul would shrink, and lower price targets would look less like a reaction to one-off costs and more like a sober reassessment of profit expectations.

There is a counterweight. BMW has separated its completed severance programme from the structural job-reduction measures still running. The overhaul is not finished, but it can be assessed in parts rather than as one open-ended programme. If the additional charges stay confined to the measures named, their fading could lift reported profitability without any fundamental improvement in the sales environment — a possible path, not a confirmed forecast.

Dingolfing offers a catalyst, not a proof

On the product side, series production of the eighth-generation BMW 3 Series saloon began at the Dingolfing plant on Tuesday. Combustion-engine variants are built there, with plug-in hybrid versions to follow from 2027. It is a future catalyst, not yet evidence of higher profits. What counts is the economics: only when the product launch, deliveries and profitability move in step would the recovery thesis gain traction.

Until then, the margin before measures remains the more telling gauge — a firmer indicator than the simple hope that restructuring costs will run their course.